Abbott Medical Optics Inc. has launched the Healon
Duet Dual Pack ophthalmic viscosurgical device after receiving
FDA approval. According to a news release, the new
pack delivers the company’s Healon and Healon EndoCoat
viscoelastics each in a separate sterile tray within one convenient
package, allowing physicians t…
Category: Refractive
OptiMedica Granted Fundamental Patent on Laser Cataract Surgery
The US Patent and Trademark Office has granted
OptiMedica Corporation a patent relating to the fundamental
technology underlying laser cataract surgery.
The patent, issued on March 12, 2013, as US patent
no. 8394084, contains broad claims and describe…
Legislation Introduced to End SGR Formula for Physicians’ Reimbursement
Legislation to end the sustainable growth rate (SGR)
formula for physician reimbursement under Medicare and
replace it with yearly payment increases was introduced by
US Representatives Allyson Schwartz, D-Pa., and Joe Heck,
DO, R-Nev., on February 7, …
ASCRS Issues Medication Alert for LASIK and PRK
The American Society of Cataract and Refractive
Surgery (ASCRS) Cornea and Refractive Surgery Clinical
Committees issued a joint alert regarding the use of topical
medications immediately prior to or intraoperatively during
LASIK and PRK.
According to…
Improvements in BCVA After Cataract Surgery in Nanophthalmic Eyes Despite Complications
Although cataract surgery in patients with nanophthalmos
remains a surgical challenge, and complications often
occur in these high-risk eyes, it is a relatively safe procedure
with improvements in BCVA, according to a study in
Ophthalmology.sup1/sup
T…
Haze Prevented in PRK Eyes With 5-Second Application of MMC
Short-time application of mitomycin C (MMC) 0.02%
was safe and effective in preventing haze formation in eyes
having PRK for low myopia, according to a study in the
Journal of Cataract and Refractive Surgery.sup1/sup
In the prospective, sham-controlle…
Topical MMC Not Associated With Measurable Systemic Absorption
Corneal topical application of mitomycin C (MMC) did
not result in measurable plasma levels of systemic absorption
after refractive surgery, according to a study in the
Journal of Cataract and Refractive Surgery.sup1/sup
The study included male and fe…
Allergan to Buy MAP Pharmaceuticals for $958 Million
Allergan, Inc., has agreed to pay nearly $1 billion to
acquire MAP Pharmaceuticals, a biopharmaceutical company
focused on developing and commercializing new
therapies in neurology, the two companies announced in
a news release. The purchase price of $25 a share in cash
is a 60% premium over MAP’s closing price of $1…
Profile of Choroidal Thickness Different in High Myopess
Axial length was associated with choroidal thickness in
high myopes, and the choroidal thickness profile in these
patients differed from emmetropes, according to a study
in the American Journal of Ophthalmology.sup1/sup
The retrospective, comparative,…
Sightpath Medical to Launch Mobile Femtosecond Laser Cataract Surgery Service
Sightpath Medical announced that it will launch its
mobile femtosecond laser for cataract surgery early this
year. The new service suite called MoFe will include a femtosecond
laser, an intraoperative wavefront aberrometer,
and a certified laser engine…
Obama Honors LASIK Inventor
Gholam Peyman, an Arizona surgeon and inventor
of LASIK surgery, was honored at the White House
this month by President Barack Obama along with
10 other inventors receiving the National Medal of
Technology and Innovation.
Dr. Peyman practices at Arizo…
Two Acquisitions Announced
Alcon Laboratories, Inc., acquired the ophthalmic division
of SensoMotoric Instruments, according to a company
news release. The acquisition provides Alcon with
ocular surgical guidance technology for use in cataract
surgery, such as real-time eye trac…
Corneal Astigmatism Common Before Cataract Surgery in Chinese Patients
The distribution of corneal astigmatism largely fell
between 0.25 D and 1.25 D before cataract surgery in
Chinese patients, according to a study in the Journal of
Cataract and Refractive Surgery.sup1/sup
From July 2009 to May 2011, the investigators
p…
LipiView Version 2.0 Software Receives FDA Clearance
The FDA has cleared additional features and broadened
the indication for the use of the LipiView Ocular
Surface Interferometer (TearScience, Inc.), according to
a news release. The device can now measure the absolute
thickness of the tear film lipid la…
Sulcus-Diameter–Based Formula Achieved Predictable Sizing of Visian ICL
Significantly better predictability of postoperative vault
height was achieved by including a sulcusdiameter–
based formula in the sizing formula for the
Visian Implantable Collamer Lens (ICL; STAAR Surgical)
compared with only using the traditional white-towhite–
based formula, according to a study in the Journal
…
Bausch + Lomb Completes Acquisition of Technolas Perfect Vision GmbH
Bausch + Lomb has completed its acquisition of
Technolas Perfect Vision GmbH. The new entity will
be known as Bausch + Lomb Technolas, according to a
company news release. The financial terms of the deal
were not disclosed.
Technolas Perfect Vision will become part of Bausch
+ Lomb’s surgical business, and its fem…
Alcon and Bausch + Lomb Each Release New Treatment Options for Postoperative Pain and Inflammation
At the Hawaiian Eye meeting in Waikoloa, Hawaii,
Alcon Laboratories, Inc., and Bausch + Lomb separately
announced the US release of treatments for pain and
inflammation following cataract surgery.
Alcon launched Ilevro (nepafenac ophthalmic suspension…
InSite Vision Completes Phase 3 Clinical Study of BromSite
The final patient has completed dosing and evaluation
in InSite Vision’s phase 3 clinical trial of BromSite (ISV-
303) for the reduction of pain and inflammation after
cataract surgery. BromSite combines a low dose (0.075%)
of the agent bromfenac with InSite Vision’s DuraSite
drug-delivery technology. Top-line data…
Bausch + Lomb Announces Partnership With Cirle, Inc.
Aiming to be better positioned to explore novel,
early-stage, ophthalmic technologies and develop them
into innovations that fill unmet needs, Bausch + Lomb
announced a research partnership with Cirle, Inc., a
Miami-based medical technology incubator.
…
LenSx Laser Receives New FDA Clearance for the Creation of the Corneal Flap
The LenSx Laser (Alcon Laboratories, Inc.) has received
FDA clearance for the corneal flap’s creation in refractive
procedures.
With the new indication, the LenSx Laser platform will
enable physicians to deliver customized treatments based
on a pati…